cdr

Hot Keywords
Drug Resistance Mechanisms Epigenetic Resistance in Cancer Therapy Biomarkers Pharmacogenetics of Cancer Liquid Biopsy Targeted Cancer Therapy Non-coding RNAs Kinase Inhibitors ABC Transporters

Top
Partners

Cooperating conferences

Leipzig Immune ONcology (LION) Conference

Time and Venue: 9-10 November 2021 | Virtual Conference

About: The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. The annual meeting is organized by the Fraunhofer Institute for Cell Therapy and Immunology and the University Cancer Center of the University Hospital Leipzig. It will be held under the auspices of the German Society of Hematology and Medical Oncology (DGHO).
We are looking forward to welcoming you virtually on 9-10 November 2021 at LION 2021.

Website: http://www.lion-conference.com/

Previous conferences

7th Immunotherapy of Cancer Conference (ITOC7)

Time and Venue: 2-3 October 2020 | Virtual Conference

About: The 7th Immunotherapy of Cancer Conference (ITOC7) to be held in Munich, Germany from October 2-3, 2020 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation to address its unique challenges.
ITOC7 is organized by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.

Website: https://www.itoc-conference.eu/

EORTC-PAMM Meeting

Time and Venue: 21-22 April 2021 | Virtual Event

About: EORTC is an independent, non-profit cancer research organization, our mission is to coordinate and conduct international translational and clinical research to improve the standard of cancer treatment for patients. The aim ultimately to increase people’s survival and quality of life by testing new therapeutic strategies based on existing drugs, surgery and radiotherapy. We also help develop new drugs and approaches in partnership with the pharmaceutical industry and in patients’ best interests.
The EORTC-PAMM groups appreciates the kind willingness of the journal Cancer Drug Resistance to sponsor two awards for the best presentation on each day of the meeting.

Website: https://www.eortc.org/event/eortc-pamm-meeting/

Immuno Week: Online

Time and Venue: 6-9 July 2021 | BST (UTC+1)

About: Oxford Global is proud to present Immuno Week: Online, taking place 6 – 9 July 2021. Across the week, expert speakers will provide you with a forward-looking perspective on the opportunities and challenges impacting market growth in immuno-oncology from discovery through to the clinic.  

Register for Free: https://www.oxfordglobal.co.uk/immuno-series-uk-virtual/book-now/ 

The four-day congress offers an interactive online platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions. It will bring together over 800 senior industry experts and key opinion leaders in immuno-oncology.

Website: https://www.oxfordglobal.co.uk/immuno-series-uk-virtual/

The SOHO (Society of Hematologic Oncology) 3rd Italian Conference

Time and Venue: 27-30 September 2021 | Rome-Italy

About: The SOHO (Society of Hematologic Oncology) 3rd Italian Conference, is bringing together leading SOHO experts and top Italian researchers in leukemias, lymphomas, multiple myeloma, MPNs, MDSs, and rare diseases, with the aim to consolidate the Italian Hematology-SOHO partnership.
It will cover the latest advances in the pathophysiology and therapy of hematological malignancies such as: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma, Non Hodgkin and Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndromes, Myeloproliferative Neoplasms, Myelofibrosis.
It also serves to spread the importance to the Italian Scientific Community about the new scientific society "ITALIAN SOCIETY OF HEMATOLOGIC ONCOLOGY" (SOHO ITALY).
The aim of the association is the integration of the clinical-scientific activities of IRST Meldola and MD ANDERSON CANCER CENTER and the improvement of the clinical-therapeutic approach to patients with hematologic malignancies.
The Society "SOHO ITALY" is represented by G. Martinelli and C. Cerchione (IRST MELDOLA) and H. Kantarjian, E. Jabbour, M. Konopleva, N. Daver.
The Italian Society of Hematologic Oncology (SOHO Italy) was established as a non-profit organization in 2019 to promote worldwide research (education, prevention, clinical studies and patient care) into hematologic malignancies and related disorders. The Italian SOHO network, related to American SOHO network, aims to compare Italian and American management of hematologic malignancies, and to share most innovative updates in this field.

Website: https://www.sohoitaly.it/2021-soho-italy-conference/

8th Immunotherapy of Cancer Conference (ITOC8)

Time and Venue: 8-9 October 2021 | Virtual Conference

About: The 8th Immunotherapy of Cancer Conference (ITOC8) is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.
ITOC8 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery

Website: https://www.itoc-conference.eu/

© 2016-2021 OAE Publishing Inc., except certain content provided by third parties